BML Pharmaceuticals Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

BML Pharmaceuticals General Information

Description

Developer of proprietary prescriptive pharmaceutical products in the areas of cancer treatment. The company's products are formulated into therapeutics which range from the prevention and treatment of dermal disease to mucositis for cancer patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 1129 Northern Boulevard
  • Suite 406
  • Manhasset, NY 11030
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BML Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BML Pharmaceuticals‘s full profile, request access.

Request a free trial

BML Pharmaceuticals Patents

BML Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-6537526-B2 Triclosan in combination with a non-toxic polyhydric alcohol and a poloxamer. Expired - Lifetime 08-May-2001 00000000 0
US-20020187107-A1 Triclosan in combination with a non-toxic polyhydric alcohol and a poloxamer. Granted 08-May-2001 00000000 0
US-20040091428-A1 Treating mucositis, herpetic infections or fungal infections by contacting the affected area with an amount of composition which comprises triclosan or a combination of triclosan and a cationic antibacterial compound in an amount which will Abandoned 04-Jan-1999 000000000 00
US-5945089-A Contacting the affected area of oral mucosa with an amount of a formulation containing triclosan Expired - Lifetime 05-Nov-1998 0000000000 00
CA-2187260-C Alkaline oral hygiene composition Expired - Fee Related 06-Oct-1995 A61Q11/00
To view BML Pharmaceuticals’s complete patent history, request access »

BML Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Barry Libin Chairman & Chief Executive Officer
To view BML Pharmaceuticals’s complete executive team members history, request access »

BML Pharmaceuticals Board Members (1)

Name Representing Role Since
00000 00000 Self Chairman & Chief Executive Officer 000 0000
To view BML Pharmaceuticals’s complete board members history, request access »

BML Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BML Pharmaceuticals‘s full profile, request access.

Request a free trial